Regulations and guidelines governing stem cell based products: Clinical considerations. - Wikidata - awgldk - TriplyDB

Regulations and guidelines governing stem cell based products: Clinical considerations.

Regulations and guidelines governing stem cell based products: Clinical considerations.

http://www.wikidata.org/entity/Q35173932

about

Endpoints in stem cell trials in ischemic heart failure Cell therapy of periodontium: from animal to human?Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations.Cellular reprogramming for understanding and treating human disease.The regulatory sciences for stem cell-based medicinal products.Stem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.The potential impact of bone tissue engineering in the clinic Microparticles to enhance delivery of drugs and growth factors into wound sites.Stem cells, dot-com.Considering Cell Therapy Product "Good Manufacturing Practice" Status.Reflection and observation: cell-based screening failing to detect HBV in HUMSCs derived from HBV-infected mothers underscores the importance of more stringent donor eligibility to reduce risk of transmission of infectious diseases for stem cell-bas Peptidhydrogele für den Einsatz von Stammzellen in der regenerativen Medizin

P2860

Q26796330-D3780073-BD61-42B1-8455-A45E5EA8C5F9 Q26822784-0968CDA1-8AC5-41DE-AB25-05629C41CF51 Q33905385-96BC394F-4A35-4DD8-AD08-02BBDBFB379C Q34496408-9D368775-1F23-4EB8-8AE7-925656B6B178 Q38204699-B38BF647-31BF-477A-A638-066717EA17A6 Q38432028-129359CC-C4AB-4E22-A90F-8CCD2D133943 Q38934189-EEE4BD04-4ECB-4505-BD12-19102D76A6F2 Q38993469-32911E5A-18A4-4466-B98C-5FE47659E0B8 Q43957462-085A9714-D1C0-47EF-9E9F-F447135C301A Q55429940-F8320141-8A43-4298-B112-073917EA70A7 Q55518637-8C0065C3-173E-439F-B121-95A4981C531F Q58063470-78DD9CC5-83BD-43FB-8159-22C6667F465E

P2860

Regulations and guidelines governing stem cell based products: Clinical considerations.

http://www.wikidata.org/entity/Q35173932

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Regulations and guidelines governing stem cell based products: Clinical considerations.

@ast

Regulations and guidelines governing stem cell based products: Clinical considerations.

@en

type

label

Regulations and guidelines governing stem cell based products: Clinical considerations.

@ast

Regulations and guidelines governing stem cell based products: Clinical considerations.

@en

prefLabel

Regulations and guidelines governing stem cell based products: Clinical considerations.

@ast

Regulations and guidelines governing stem cell based products: Clinical considerations.

@en

P1433

Q35173932-5BC8046F-EA61-46A7-A017-A815FDF71CA0

P1476

Q35173932-08689258-9E7E-4880-BCBC-C63623F031E4

P2093

Q35173932-26B7E40F-7ED9-4673-B96B-A375C74A119F

P2860

Q35173932-0B30CE3F-E8C4-4B4C-803E-3547419A263E

Q35173932-28A68C4D-6B65-4EF3-AA21-6510B40282F3

Q35173932-36AD32E5-E981-457F-A3D8-92CB9A1BE97B

Q35173932-3E571AC5-1C08-4E11-9007-081E0E19D628

Q35173932-424CC3AE-56AA-42EA-AD57-1D5FEA2FB92D

Q35173932-82DCC4E4-388F-44B2-856A-8FE819E8881C

Q35173932-A202DF98-BD0F-473F-AA70-A2D7BA605786

Q35173932-A6BFE5E4-27DE-4026-9CC5-87DAB4AA3351

Q35173932-A99307A9-6A90-4AA5-B451-DC18FA42A172

Q35173932-ABD60CB9-FA2F-45B6-9417-C3C1D3C8EDFB

P304

Q35173932-11FA869D-BB4C-4BFA-8988-68F8158D6547

P31

Q35173932-B2A23045-459A-419F-9D4F-E134944A2575

P356

Q35173932-CC434DC0-B35A-45DF-9E80-F3F0E7FC27E8

P433

Q35173932-8C06195A-F39A-4001-BF31-C6DB75915135

P478

Q35173932-9399BC61-9874-4911-8FA7-F09D71E34F30

P577

Q35173932-847891FB-CA48-4C97-A143-DCE11AF80F69

P698

Q35173932-6429F11B-981A-4FB7-A3B3-8A31EE662BF3

P932

Q35173932-3ADD917F-0EFF-4243-A6E8-730BD12607DD

P356

2229-3485.83228

P1433

Perspectives in Clinical Research

P1476

Regulations and guidelines governing stem cell based products: Clinical considerations.

@en

P2093

Bobby George

http://www.w3.org/2001/XMLSchema#string

P2860

Off-label prescribing: a call for heightened professional and government oversight

Bone marrow derived stem cells in regenerative medicine as advanced therapy medicinal products.

Concise review: mind the gap: challenges in characterizing and quantifying cell- and tissue-based therapies for clinical translation.

Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects.

Translating research into clinical scale manufacturing of mesenchymal stromal cells.

Mesenchymal stem-cell therapy in a regulated environment.

An international consortium on stem cells, ethics and law.

Mesenchymal stem cells: revisiting history, concepts, and assays.

The long journey from stem cells to medical product.

Gaps and overlaps: improving the current regulation of stem cells in the UK.

P304

94-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/2229-3485.83228

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21897884

http://www.w3.org/2001/XMLSchema#string

P932

3159216

http://www.w3.org/2001/XMLSchema#string